VERTEX PHARMACEUTICALS INC / MA Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) of $0 for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-07-26.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds · last filed 2018-07-26
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for fiscal 2017 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for fiscal 2015 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA available-for-sale securities, gross realized gains (losses), sale proceeds (deprecated 2018-01-31) for fiscal 2014 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $0.00 10-Q · filed 2018-07-26 | $0.00 derived: sum of 2 quarters · filed 2018-07-26 | $0.00 derived: sum of 3 quarters · filed 2018-07-26 | $0.00 derived: sum of 4 quarters · filed 2018-07-26 |
| 2018-03-31 | $0.00 10-Q · filed 2018-04-27 | $0.00 derived: sum of 2 quarters · filed 2018-04-27 | $0.00 derived: sum of 3 quarters · filed 2018-04-27 | $0.00 derived: sum of 4 quarters · filed 2018-07-26 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $0.00 derived: sum of 2 quarters · filed 2018-02-15 | $0.00 derived: sum of 3 quarters · filed 2018-07-26 | $0.00 10-K · filed 2018-02-15 |
| 2017-09-30 | $0.00 10-Q · filed 2017-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-07-26 | $0.00 10-Q · filed 2017-10-30 | $0.00 derived: sum of 4 quarters · filed 2018-07-26 |
| 2017-06-30 | $0.00 10-Q · filed 2018-07-26 | $0.00 10-Q · filed 2017-07-28 | $0.00 derived: sum of 3 quarters · filed 2018-07-26 | $0.00 derived: sum of 4 quarters · filed 2018-07-26 |
| 2017-03-31 | $0.00 10-Q · filed 2018-04-27 | $0.00 derived: sum of 2 quarters · filed 2018-04-27 | $0.00 derived: sum of 3 quarters · filed 2018-04-27 | $0.00 derived: sum of 4 quarters · filed 2018-04-27 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $0.00 derived: sum of 2 quarters · filed 2018-02-15 | $0.00 derived: sum of 3 quarters · filed 2018-02-15 | $0.00 10-K · filed 2018-02-15 |
| 2016-09-30 | $0.00 10-Q · filed 2017-10-30 | $0.00 derived: sum of 2 quarters · filed 2017-10-30 | $0.00 10-Q · filed 2017-10-30 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-07-28 | $0.00 10-Q · filed 2017-07-28 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-04-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-15 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |